Glaucoma Trial, Recruiting NCT06313749 Sponsor: Sanoculis Ltd Condition: Glaucoma
Back to Glaucoma

Glaucoma Trial, Recruiting

NCT06313749
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People aged 40 to 85 years old (male or female)
  • People who have been diagnosed with a type of glaucoma called primary open-angle glaucoma, where eye pressure is not well controlled even while taking multiple eye pressure-lowering medications, with eye pressure readings between 21 and 40 mmHg at screening
  • People whose glaucoma diagnosis is supported by vision field test results showing a certain level of loss (-3dB or worse), along with visible damage to the optic nerve or the nerve fibre layer at the back of the eye, confirmed through specialist eye examination or photographs
  • People who have healthy, flexible, and moveable tissue (conjunctiva) covering the white of the eye in the area where the procedure would be performed
  • People who had a previous minimally invasive glaucoma procedure (such as iStent, Trabectome, or GATT) performed more than 6 months before joining the trial
  • People who are able and willing to attend all required follow-up appointments
  • People who understand the trial information and are willing to sign a consent form

Who may not be able to join:

  • No exclusion criteria were listed in the provided information (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 22 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 8082862666

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Sanoculis Ltd
Registry
ClinicalTrials.gov
Start date
1 June 2024
Est. completion
1 December 2025

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Surgical success rate of the MIMS® device/procedure at 12 months after surgery

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov